Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy

@article{Yang2015HepatitisBV,
  title={Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy},
  author={Yu Yang and Yang Du and Wu-Xia Luo and Cong Li and Ye Hong Chen and Ke Cheng and Jing Ding and Yi Zhou and Jun Ge and Xian Hui Yang and Jiyan Liu},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2015},
  volume={75},
  pages={783-790}
}
The objectives of this study were to investigate the incidences of hepatitis B virus (HBV) reactivation and hepatitis in gastrointestinal cancer patients with positive hepatitis B surface antigen (HBsAg) after chemotherapy and assess the effect of antiviral therapy on preventing HBV reactivation and hepatitis. The medical records of gastric or colorectal cancer patients with positive HBsAg undergoing chemotherapy in West China Hospital were reviewed from January 2009 to August 2014. One hundred… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 26 references

a randomized trial

  • C Hsu, CA Hsiung, IJ Su, WS Hwang, MC Wang, lymphoma Lin SF et al A revisit of prophylactic lamivudine non-Hodgkin’s
  • Hepatology 47:844–853 790 Cancer Chemother…
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…